Concurrent Tuberculosis and COVID-19 Testing from a Single Sputum Specimen for Enhanced Disease Detection
Open Access
- 13 March 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 15 (6) , 720
Abstract
Background/Objectives: Tuberculosis (TB) and SARS-CoV-2 share similar symptoms and transmission routes. In early 2021, USAID and Stop TB Partnership recommended an integrated approach for simultaneous COVID-19 and TB testing in high TB burden countries for individuals with respiratory symptoms. In this evaluation, we tested a single sputum for both SARS-CoV-2 and Mycobacterium tuberculosis complex (MTBC) from participants at two healthcare facilities in South Africa. The diagnostic accuracy of the Xpert Xpress SARS-CoV-2 (Xpress) assay using a sputum swab capture method was assessed by comparing the results with routine SARS-CoV-2 testing, while also determining the prevalence of TB and TB-COVID-19 co-infection in the study population. Methods: A total of 2274 individuals were screened for enrolment. Eligibility included the presence of respiratory symptoms, close contact with a person with TB, TB diagnosis in the last two years or a person living with HIV. Sputum from 1032 participants was tested on the Xpress assay using a swab capture method while residual sputum was tested on the Xpert MTB/RIF Ultra assay for MTBC and rifampicin-resistance detection. Concordance between the Xpress assay and routine SARS-CoV-2 testing was assessed. Results: The Xpress assay detected SARS-CoV-2 in 183/1032 (18%) participants, TB was detected in 35/1032 (3%) participants and 10/1032 (1%) participants were co-infected with TB and COVID-19. The Xpress assay showed substantial agreement with routine testing (Kappa: 0.755). Conclusions: The study findings underscore a substantial identification of TB and rifampicin-resistant TB that would have been missed if bi-disease testing was not performed. In addition, the sputum swab capture method demonstrated reliable performance for SARS-CoV-2 detection.Keywords
All Related Versions
Funding Information
- Bill and Melinda Gates Foundation (OPP1171455)
This publication has 22 references indexed in Scilit:
- Systematic review and meta-analysis of Tuberculosis and COVID-19 Co-infection: Prevalence, fatality, and treatment considerationsPLOS Neglected Tropical Diseases, 2024
- Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational studyThe Lancet Global Health, 2022
- COVID-19: Impact on the HIV and Tuberculosis Response, Service Delivery, and Research in South AfricaCurrent HIV/AIDS Reports, 2022
- Saliva swabs are the preferred sample for Omicron detectionmedRxiv, 2021
- Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data showBMJ, 2021
- Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effectsPulmonology, 2021
- Cough-independent production of viable Mycobacterium tuberculosis in bioaerosolTuberculosis, 2021
- Subclinical Tuberculosis Disease—A Review and Analysis of Prevalence Surveys to Inform Definitions, Burden, Associations, and Screening MethodologyClinical Infectious Diseases, 2020
- Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19Infectious Diseases, 2020
- Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural ZimbabwePLOS ONE, 2018